Xiaoli Shi

913 citations
35 papers · 716 indexed · h-index 13
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Peptidase Inhibition and Analysis (4 papers)Cancer-related molecular mechanisms research (4 papers)

In The Last Decade

Xiaoli Shi

32 papers receiving 711 citations

Peers

Xiaoli Shi
Comparison fields: 5 of 83
  • Molecular Biology 267
  • Cancer Research 181
  • Oncology 141
  • Hematology 130
  • Epidemiology 108
Replace Marnie A. Ryan with:
Marnie A. Ryan United States
Dariusz Zakrzewicz Germany
Benyan Wu China
Jana Nekvindová Czechia
Tiantian Sun China
Jiandong Zhang China
Jingshu Geng China
Sharlene Velichko United States
Fei‐Ran Gong China
Yongqiang Li China
Xiaoli Shi relative to Marnie A. Ryan United States Marnie A. Ryan's profile →
Citations per field
00.5×
Marnie A. Ryan · 1×
Citations per year

Countries citing papers authored by Xiaoli Shi

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Shi more than expected).

Fields of papers citing papers by Xiaoli Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Shi. The network helps show where Xiaoli Shi may publish in the future.

Co-authorship network of co-authors of Xiaoli Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Shi. A scholar is included among the top collaborators of Xiaoli Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Shi. Xiaoli Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 0
4 0
5 3
6 1
7 2
8 1
9 13
10 6
11 6
12 5
13 19
14 10
15 25
16 15
17 13
18 39
19 96
20 13

About Xiaoli Shi

Xiaoli Shi is a scholar working on Cancer Research, Animal Science and Zoology and Aquatic Science, having authored 35 papers that have together received 716 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Otorhinolaryngology (64 citations), Cancer Research (181 citations) and Hematology (130 citations). Xiaoli Shi has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Barbara M. Mueller, Lawrence F. Brass, Beena Gangadharan, Wolfram Ruf, Jing Wu, Qi Wang, Yong Shi, Ling Lü, Ping Jiang and Juan Bai. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Biochemical and Biophysical Research Communications and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026